False positive findings in primary tumor and metastasis diagnostics by FDG-
PET due to FDG-uptake in inflammatory foci are documented in literature. Th
e demonstrated case reveals that increased uptake of FDG in activated neutr
ophile granulocytes and macrophages has to be taken into consideration in t
herapy control under chemotherapy, too. In a 53 year old patient FDG-PET wa
s performed after chemotherapy of an abdominal Non-Hodgkin lymphoma for eva
luation of persistent tumor vitality. The margin of the persisting mass sho
wed increased uptake of glucose. Histology documented a necrotic center sur
rounded by granulation tissue.